Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Julia K Tietze"'
Autor:
Anna Martina Jötten, Simon V. Neidinger, Julia K. Tietze, Julia Welzel, Christoph Westerhausen
Publikováno v:
Biophysica, Vol 1, Iss 4, Pp 445-457 (2021)
The detection and enrichment of circulating melanoma cells is a challenge, as the cells are very heterogeneous in terms of their biomechanical properties and surface markers. In addition, there is a lack of valid and reliable biomarkers predicting pr
Externí odkaz:
https://doaj.org/article/c65aa8f48b794892bfa16cbf5fbc52ec
Autor:
Katharina Seidel, Lutz F. Tietze, Christian Braun, Miriam Mann, Anette Kerschnitzki, Julia K. Tietze
Publikováno v:
European Journal of Dermatology. 33:19-24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb6642f678bf370f4609087d5ded544f
https://doi.org/10.1684/ejd.2023.4406
https://doi.org/10.1684/ejd.2023.4406
Autor:
Julia K. Tietze
Publikováno v:
Die Dermatologie. 73:929-936
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35e2a64a33248fca3c2c2039cbdf9111
https://doi.org/10.1007/s00105-022-05076-4
https://doi.org/10.1007/s00105-022-05076-4
Publikováno v:
Biophysica
Volume 1
Issue 4
Pages 32-457
Biophysica, Vol 1, Iss 32, Pp 445-457 (2021)
Volume 1
Issue 4
Pages 32-457
Biophysica, Vol 1, Iss 32, Pp 445-457 (2021)
The detection and enrichment of circulating melanoma cells is a challenge, as the cells are very heterogeneous in terms of their biomechanical properties and surface markers. In addition, there is a lack of valid and reliable biomarkers predicting pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e716fd86213925dc6312fa0db555dcf9
https://doi.org/10.3390/biophysica1040032
https://doi.org/10.3390/biophysica1040032
Autor:
Julia K, Tietze
Publikováno v:
Dermatologie (Heidelberg, Germany)Literatur. 73(12)
Melanoma is a highly immunogenic cancer with an increased infiltration of lymphocytes (TIL). TIL are a very heterogeneous population which consists among others of CD8+ T cells, CD4+ T cells, regulatory T cells, B cells, and natural killer (NK) cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a3eda4e20628253a1c7a065056b45ac9
https://pubmed.ncbi.nlm.nih.gov/36401123
https://pubmed.ncbi.nlm.nih.gov/36401123
Autor:
Alexander Schulz, Jennifer Raetz, Paula C. Karitzky, Lisa Dinter, Julia K. Tietze, Isabell Kolbe, Theresa Käubler, Bertold Renner, Stefan Beissert, Friedegund Meier, Dana Westphal
Publikováno v:
Cancers; Volume 14; Issue 19; Pages: 4930
BRAFV600 mutations in melanoma are targeted with mutation-specific BRAF inhibitors in combination with MEK inhibitors, which have significantly increased overall survival, but eventually lead to resistance in most cases. Additionally, targeted therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3506717e5c936b207c6145f13e641100
https://pubmed.ncbi.nlm.nih.gov/36230853
https://pubmed.ncbi.nlm.nih.gov/36230853
Autor:
Alexander Thiem, Pegah Mashhadiakbar, Christiane Cussigh, Jessica C. Hassel, Imke Grimmelmann, Ralf Gutzmer, Max Schlaak, Markus V. Heppt, Pia Dücker, Svea Hüning, Lena Schulmeyer, Bastian Schilling, Sebastian Haferkamp, Mirjana Ziemer, Rose K. C. Moritz, Victoria Hagelstein, Patrick Terheyden, Christian Posch, Maria R. Gaiser, Peter Kropp, Steffen Emmert, Britta Müller, Julia K. Tietze
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADVREFERENCES.
Choosing the adequate systemic treatment for melanoma is driven by clinical parameters and personal preferences.Evaluation of the impact of disease and treatment on the daily life of patients receiving systemic therapy for melanoma.A German-wide, cro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1d261900ad0fae8ba09925e67701f71
https://pubmed.ncbi.nlm.nih.gov/36433671
https://pubmed.ncbi.nlm.nih.gov/36433671
Autor:
Carsten Spitzer, Laura Lübke, Tereza Lindstädt, Christina Gallinat, Julia K. Tietze, Steffen Emmert, Alexander Thiem
Publikováno v:
Journal of psychiatric research. 147
The prevalence of pathological skin-picking (PSP) has predominantly been studied in students and the community, but not yet in dermatological patients. However, those may be at increased risk of PSP because it is often triggered by the feel or look o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e10108ba89c571868ad20d0022649dc
https://pubmed.ncbi.nlm.nih.gov/35066291
https://pubmed.ncbi.nlm.nih.gov/35066291
Autor:
Arta M Monjazeb, Julia K Tietze, Steven K Grossenbacher, Hui-Hua Hsiao, Anthony E Zamora, Annie Mirsoian, Brent Koehn, Bruce R Blazar, Jonathan M Weiss, Robert H Wiltrout, Gail D Sckisel, William J Murphy
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e102709 (2014)
We have previously demonstrated that immunotherapy combining agonistic anti-CD40 and IL-2 (IT) results in synergistic anti-tumor effects. IT induces expansion of highly cytolytic, antigen-independent "bystander-activated" (CD8(+)CD44high) T cells dis
Externí odkaz:
https://doaj.org/article/8cc561b24e474b77877ada18789ecaf1
Autor:
Dirk Schadendorf, Carmen Loquai, Felix Kiecker, Konstantin Drexler, Laura Susok, Peter Mohr, Katharina C. Kähler, Leonie Bluhm, Lydia Reinhardt, Friedegund Meier, Jessica C. Hassel, Selma Ugurel, Claudia Pföhler, Sarah Knispel, Bastian Schilling, Christopher G. Cann, Simone M. Goldinger, Elisabeth Livingstone, Andreas Stang, Thomas Eigentler, Cindy Franklin, Julia K. Tietze, Maria Isabel Fleischer, Carola Berking, Paolo A. Ascierto, Judith Sirokay, Carsten Weishaupt, Patrick Schummer, Lisa Zimmer, Georgina V. Long, Maximilian Gassenmaier, Carina N. Owen, Lucie Heinzerling, Raphael R. Reinhard, Douglas B. Johnson, Kai Martin Thoms, Alexander M. Menzies, Dennis Niebel, Ralf Gutzmer
Publikováno v:
European journal of cancer (Oxford, England : 1990). 148
Background Elevated lactate dehydrogenase (LDH) is a known predictive and prognostic factor for a poor outcome in patients with metastatic melanoma. It is unclear whether first-line targeted therapy (TT) or immune checkpoint inhibition (ICI) is more
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a7b5b295efc1524ab0bf2996f38c02f
https://pubmed.ncbi.nlm.nih.gov/33735811
https://pubmed.ncbi.nlm.nih.gov/33735811